Back to Market Feed

Historical record - last NADAC effective date: 8/22/2018

Product Information

GLYBURID-METFORMIN 1.25-250 MG is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0529 per EA under NDC 68382065301. Its NADAC has been published 103 times since Sep 21, 2016.

FDA first approved this application on Feb 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GLYBURID-METFORMIN 1.25-250 MG

glyburide and metformin hydrochloride
$0.0529per EA

Strength

1.25; 250 mg/1; mg/1

NDC

68382065301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/22/2018

Approval Type

Generic (ANDA)

FDA Application

ANDA206748

FDA Approved

2/29/2016

TE Code

AB

On Market Since

4/7/2016

Pharmacological Classes

Biguanide
Biguanides
Sulfonylurea Compounds
Sulfonylurea

Price Statistics

The NADAC for GLYBURID-METFORMIN 1.25-250 MG has been published 103 times since Sep 21, 2016, and over the history we have for it it has declined 40.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0529 per EA
All-time high$0.0883 (Oct 12, 2016)
All-time low$0.0461 (Nov 22, 2017)
Median price$0.0577
Average price$0.0548
Largest weekly change-30.0% (Oct 19, 2016)
Weeks tracked103
Tracking sinceSep 21, 2016

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-40.1%

Last surveyed Sep 5, 2018 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the glyburide and metformin hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

METFORMIN HCL 500 MG TABLET
Generic
71093013204•ACI Healthcare USA, Inc.
$0.0140
per EA
METFORMIN HCL 500 MG TABLET
Generic
71093013205•ACI Healthcare USA, Inc.
$0.0140
per EA
METFORMIN HCL 500 MG TABLET
Generic
71093013206•ACI Healthcare USA, Inc.
$0.0140
per EA
METFORMIN HCL 500 MG TABLET
Generic
00378718505•Mylan Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
00904716261•Major Pharmaceuticals
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084101•Heritage Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084105•Heritage Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084110•Heritage Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094701•Laurus Labs Limited
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094705•Laurus Labs Limited
$0.0142
per EA

Frequently asked questions

What is the NADAC price of GLYBURID-METFORMIN 1.25-250 MG?

The current National Average Drug Acquisition Cost (NADAC) for GLYBURID-METFORMIN 1.25-250 MG, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0529 per EA (NDC 68382065301), effective Sep 5, 2018.

How has the price of GLYBURID-METFORMIN 1.25-250 MG changed over time?

Over the history we have for it, the NADAC for GLYBURID-METFORMIN 1.25-250 MG has declined 40.1%. It has been tracked across 103 weekly CMS publications since Sep 21, 2016.

What are the highest and lowest recorded NADAC prices for GLYBURID-METFORMIN 1.25-250 MG?

Since Sep 21, 2016, the NADAC for GLYBURID-METFORMIN 1.25-250 MG has ranged from a low of $0.0461 (Nov 22, 2017) to a high of $0.0883 (Oct 12, 2016), with a median of $0.0577 per EA.

Are there cheaper alternatives to GLYBURID-METFORMIN 1.25-250 MG?

No other NADAC-published product currently shares the active ingredient and strength of GLYBURID-METFORMIN 1.25-250 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GLYBURID-METFORMIN 1.25-250 MG?

GLYBURID-METFORMIN 1.25-250 MG (NDC 68382065301) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.